UBS Lowers its Price Target on Moelis & Company (MC) to $59 from $74 and Maintains a Neutral Rating

Core Viewpoint - Moelis & Company (NYSE:MC) is identified as one of the most undervalued financial stocks, despite a recent price target reduction by UBS from $74 to $59 while maintaining a Neutral rating [1][4]. Financial Performance - In Q4, Moelis & Company reported an EPS of $1.13, surpassing the consensus estimate of $0.83. Revenue reached $487.9 million, exceeding the consensus of $435.1 million [2]. - CEO Navid Mahmoodzadegan highlighted strong momentum in 2025, attributing it to the firm's robust coverage platform, and expressed confidence in the company's growth and long-term value entering 2026 [2]. Company Operations - Moelis & Company operates as an investment banking advisory firm, providing a range of services including mergers and acquisitions, recapitalizations, restructurings, capital markets transactions, strategic advisory, capital structure advisory, and private capital advisory across various global regions [4].